Gliomasphere marker combinatorics: multidimensional flow cytometry detects CD44+/CD133+/ITGA6+/CD36+ signature

Area of Science:

• Neuro-oncology
• Cancer Stem Cell Biology
• Molecular Profiling

Background:

• Glioblastoma is an aggressive brain cancer, with glioblastoma stem-like cells contributing to its lethality.
• Targeting these cells is crucial, but comprehensive co-expression analysis of known stemness markers is lacking.

Purpose of the Study:

• To map the multidimensional co-expression profile of nine key stemness-associated molecules in glioblastoma stem-like cells.
• To identify novel marker combinations predictive of patient outcomes.

Main Methods:

• Utilized gliomaspheres, an established model for glioblastoma stem-like cells.
• Applied a novel 9-marker multicolor flow cytometry panel to simultaneously measure CD133, CD44, CD15, A2B5, CD36, CXCR4, IL6R, L1CAM, and ITGA6.
• Employed viSNE dimensionality reduction for comprehensive data analysis.

Main Results:

• All gliomasphere systems expressed at least five glioblastoma stem-like cell markers.
• A consistent population expressing CD44+/CD133+/ITGA6+/CD36+ was identified across all gliomaspheres.
• Enrichment of this marker combination in glioblastoma patients correlated with significantly worse survival in TCGA datasets.

Conclusions:

• A novel, high-dimensional marker combination (CD44+/CD133+/ITGA6+/CD36+) for glioblastoma stem-like cells was identified.
• This finding highlights the importance of multi-marker combinatorics for understanding glioblastoma biology and patient prognosis.